Researchers worry that clinical vaccine trials haven't been diverse enough.
In addition, several clinical trials are partly funded by taxpayer money."The U.S. taxpayer base is getting more and more diverse," Oh told ABC News,"and as our taxpayer diversifies, that base is becoming increasingly underrepresented in the research they fund."
"The reasons why biomedical studies are under representing minority population is partly in the design and execution of studies themselves, and also because of either preferences or characteristics of study subjects that you would like to bring in," Oh said to ABC News. So, when drug companies and universities are looking for an answer to the coronavirus, how are they ensuring that their study populations are racially and ethnically diverse?
One of the first South African vaccine participants gets injected during the clinical trial for a potential vaccine against the COVID-19 at the Baragwanath hospital in Soweto, South Africa, June 24, 2020.
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Russia preparing mass vaccination against coronavirus for OctoberRussia's health minister is preparing a mass vaccination campaign against the novel coronavirus for October, local news agencies reported on Saturday, after a vaccine completed clinical trials.
Weiterlesen »
Vaccine companies searching for 1-shot dose of COVID-19 vaccineVaccine companies searching for 1-shot dose of COVID-19 vaccine.
Weiterlesen »
Small Businesses Are Fighting for Their Lives. Diversity Doesn’t Have to Be Sacrificed.For many small businesses, hiring more people during a severe downturn is a challenge. But some companies have discovered it’s possible to solve the diversity puzzle without hiring anyone new.
Weiterlesen »
Debate begins for who's first in line for COVID-19 vaccineWho will be first in line for a COVID-19 vaccine
Weiterlesen »
Top Health Official: Time To ‘Move On’ From Hydroxychloroquine Efficacy ClaimsThere's 'no evidence' to show the anti-malarial drug is effective in treating COVID-19, Adm. Brett Giroir said.
Weiterlesen »